MARC Record from marc_columbia

LEADER: 05656mam a2200409 a 4500
001 4058334
005 20221027025550.0
008 980918t19991999cauaf b 001 0 eng d
020 $a0124371906
035 $a(OCoLC)ocm39892443
035 $9ANR0802HS
035 $a(NNC)4058334
035 $a4058334
040 $aPSC$cPSC$dCOU$dNNC-M$dOrLoB-B
245 00 $aGene therapy of cancer :$btranslational approaches from preclinical studies to clinical implementation /$cedited by Edmund C. Lattime [and] Stanton L. Gerson.
260 $aSan Diego :$bAcademic Press,$c[1999], ©1999.
300 $axvii, 406 pages, 8 unnumbered pages of plates :$billustrations (some color) ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gCh. 1.$tTumor Suppressor Genes as Targets for Cancer Gene Therapy /$rRaymond D. Meng and Wafik S. El-Deiry --$gCh. 2.$tCharacterization of Specific Genetic Alterations in Cancer Cells /$rKay Huebner, Teresa Druck and Piotr Hadaczek [et al.] --$gCh. 3.$tImmunologic Targets for the Gene Therapy of Cancer /$rSuzanne Ostrand-Rosenberg, Vicky S. Gunther and Todd A. Armstrong [et al.] --$gCh. 4.$tRetroviral Vector Design for Cancer Gene Therapy /$rChristopher Baum, Wolfram Ostertag and Carol Stocking [et al.] --$gCh. 5.$tNon-Infectious Gene Transfer and Expression Systems for Cancer Gene Therapy /$rMark J. Cooper --$gCh. 6.$tParvovirus Vectors for the Gene Therapy of Cancer /$rK. K. Wong, Jr., Elizabeth Shaughnessy and Di Lu [et al.] --$gCh. 7.$tAntibody-Targeted Gene Therapy /$rA. M. McCall, G. P. Adams and L. M. Weiner --$gCh. 8.$tThe Use of Vaccinia Virus Vectors for Immunotherapy via in Situ Tumor Transfection /$rEdmund C. Lattime, Laurence C. Eisenlohr and Leonard G. Gomella [et al.] --
505 80 $gCh. 9.$tRibozymes in Cancer Gene Therapy /$rCarmela Beger, Martin Kruger and Flossie Wong-Staal --$gCh. 10.$tIn Situ Use of Suicide Genes for Cancer Therapy /$rScott M. Freeman, Rajagopal Ramesh and Anupama Munshi [et al.] --$gCh. 11.$tTransfer of Drug Resistance Genes into Hematopoietic Progenitors /$rOmer N. Koc, Brian M. Davis and Jane S. Reese [et al.] --$gCh. 12.$tCytosine Deaminase as a Suicide Gene in Cancer Gene Therapy /$rCraig A. Mullen --$gCh. 13.$tPreemptive and Therapeutic Uses of Suicide Genes for Cancer and Leukemia /$rFrederick L. Moolten and Paula J. Mroz --$gCh. 14.$tAntisense Strategies in the Treatment of Leukemias /$rBruno Calabretta, Tomasz Skorski and Gerald Zon [et al.] --$gCh. 15.$tSelectively Replicating Viruses as Therapeutic Agents against Cancer /$rDavid Kirn --$gCh. 16.$tras Oncogene Products as Tumor-Specific Antigens for Activation of T-Lymphocyte-Mediated Immunity /$rScott I. Abrams, J. Andrew Bristol and Jeffrey Schlom --
505 80 $gCh. 17.$tPolynucleotide-Mediated Immunization Therapy of Cancer /$rStephen Andrew White, Robert Martin Conry and Theresa V. Strong [et al.] --$gCh. 18.$tDNA and Dendritic Cell-Based Genetic Immunization against Cancer /$rLisa H. Butterfield, Antoni Ribas and James S. Economou --$gCh. 19.$tEngineering Cellular Cancer Vaccines: Gene and Protein Transfer Options /$rMark Tykocinski --$gCh. 20.$tCancer Gene Therapy by Direct Transfer of Plasmid DNA in Cationic Lipids /$rEvan M. Hersh --$gCh. 21.$tEx Vivo and in Vivo Cytoreductive Gene Therapy for Urologic Cancers: Translation of Molecular Pharmacology to Clinical Pharmacology /$rJonathan W. Simons, Angelo A. Baccala and Yeong Lida --$gCh. 22.$tApplications of Gene Transfer in the Adoptive Immunotherapy of Cancer /$rAlfred E. Chang and A. P. Salas --$gCh. 23.$tCytokine Gene Therapy of Cancer /$rJean-Marie Peron, Michael R. Shurin and Michael T. Lotze --
505 80 $gCh. 24.$tThe Use of Genetically Modified Hematopoietic Stem Cells for Cancer Therapy /$rLee G. Wilke and James J. Mule --$gCh. 25.$tNovel Artificial Tumor-Specific Killer Cell and Intrabody Approaches for Cancer Therapy /$rSi.-Yi Chen.
520 $aGene Therapy of Cancer represents a rapidly expanding field translating basic research concepts into new, cutting-edge technological advances. This text provides in-depth coverage of all modalities currently being used by developmental therapists to design new targeted treatments for cancer. The basic biology of cancer and cancer immunology is discussed, as are cancer targets, oncogenes, the cell cycle, induction of apoptosis, drug resistance pathways, and tumor specific antigens.
520 8 $aTherapeutic approaches include gene replacement therapies, ribozyme and antisense ligonucleotide therapies, retrovirus-mediated gene transfer, adenovirus gene transfer, nonviral approaches, tumor vaccines, engineered immunocompetent cells, and cytokine gene therapy.
650 0 $aCancer$xGene therapy.$0http://id.loc.gov/authorities/subjects/sh92005201
650 0 $aGene therapy.$0http://id.loc.gov/authorities/subjects/sh85053738
650 0 $aCancer$xImmunotherapy.$0http://id.loc.gov/authorities/subjects/sh87002642
650 12 $aNeoplasms$xtherapy.$0https://id.nlm.nih.gov/mesh/D009369Q000628
650 12 $aGenetic Therapy$xmethods.$0https://id.nlm.nih.gov/mesh/D015316Q000379
650 12 $aImmunotherapy, Adoptive$xmethods.$0https://id.nlm.nih.gov/mesh/D016219Q000379
650 22 $aProtein Biosynthesis.$0https://id.nlm.nih.gov/mesh/D014176
650 22 $aGene Transfer Techniques.$0https://id.nlm.nih.gov/mesh/D018014
700 1 $aLattime, Edmund C.,$d1951-$0http://id.loc.gov/authorities/names/n87135814
700 1 $aGerson, Stanton L.$0http://id.loc.gov/authorities/names/nb98069820
852 00 $boff,hsl$hRC271.G45$iG463 1999 Q